Stay updated on ATLAS: Etokimab in Adult Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the ATLAS: Etokimab in Adult Atopic Dermatitis Clinical Trial page.

Latest updates to the ATLAS: Etokimab in Adult Atopic Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedAdded a comprehensive list of trial locations across the United States, Canada, and Europe under the Locations section.SummaryDifference2%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe update reflects a minor version revision from v3.2.0 to v3.3.2 and does not change study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedRemoved the government funding lapse notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check59 days agoChange DetectedNo significant changes detected to the Study Details page (NCT03533751) in the screenshots; content and sections appear unchanged.SummaryDifference0.3%

- Check80 days agoChange DetectedCore content updated with operating-status notice and new version v3.2.0; old v3.1.0 removed.SummaryDifference2%

- Check87 days agoChange DetectedUpdates include a new revision label (v3.1.0) and removal of several drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the prior content.SummaryDifference0.3%

Stay in the know with updates to ATLAS: Etokimab in Adult Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ATLAS: Etokimab in Adult Atopic Dermatitis Clinical Trial page.